Methods for producing multivalent antigen-binding proteins
    2.
    发明授权
    Methods for producing multivalent antigen-binding proteins 失效
    产生多价抗原结合蛋白的方法

    公开(公告)号:US6025165A

    公开(公告)日:2000-02-15

    申请号:US166750

    申请日:1998-10-05

    摘要: Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.

    摘要翻译: 描述和要求保护编码的遗传结构的组合物和用于产生多价抗原结合蛋白的方法。 所述方法包括纯化含有单一和多价形式的单一多肽链分子的组合物,以及从纯化单体产生多价蛋白质。 多价蛋白质的产生可以通过单体蛋白质的浓度依赖性缔合,或通过重新排列涉及解离的区域,然后重新结合不同的区域来进行。 在本发明中制备了包含同型和异二价蛋白质的二价蛋白质。 公开了编码二价单链抗原结合蛋白的遗传序列。 用途包括适用于单克隆和多克隆抗体及其片段的所有应用,包括用作双特异性抗原结合分子。

    Multivalent antigen-binding proteins
    3.
    发明授权
    Multivalent antigen-binding proteins 失效
    多价抗原结合蛋白

    公开(公告)号:US06515110B1

    公开(公告)日:2003-02-04

    申请号:US09443213

    申请日:1999-11-19

    IPC分类号: C12P2108

    摘要: Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.

    摘要翻译: 描述和要求保护编码的遗传结构的组合物和用于产生多价抗原结合蛋白的方法。 所述方法包括纯化含有单一和多价形式的单一多肽链分子的组合物,以及从纯化单体产生多价蛋白质。 多价蛋白质的产生可以通过单体蛋白质的浓度依赖性缔合,或者通过重新排列涉及解离的区域,然后重新结合不同的区域来进行。 在本发明中制备了包含同型和异二价蛋白质的二价蛋白质。 公开了编码二价单链抗原结合蛋白的遗传序列。 用途包括适用于单克隆和多克隆抗体及其片段的所有应用,包括用作双特异性抗原结合分子。

    Nucleic acid molecules encoding single-chain antigen-binding proteins
    6.
    发明授权
    Nucleic acid molecules encoding single-chain antigen-binding proteins 失效
    编码单链抗原结合蛋白的核酸分子

    公开(公告)号:US06103889A

    公开(公告)日:2000-08-15

    申请号:US172019

    申请日:1998-10-14

    摘要: Compositions of, genetic constructions coding for, and methods for producing multivalent antigen-binding proteins are described and claimed. The methods include purification of compositions containing both monomeric and multivalent forms of single polypeptide chain molecules, and production of multivalent proteins from purified monomers. Production of multivalent proteins may occur by a concentration-dependent association of monomeric proteins, or by rearrangement of regions involving dissociation followed by reassociation of different regions. Bivalent proteins, including homobivalent and heterobivalent proteins, are made in the present invention. Genetic sequences coding for bivalent single-chain antigen-binding proteins are disclosed. Uses include all those appropriate for monoclonal and polyclonal antibodies and fragments thereof, including use as a bispecific antigen-binding molecule.

    摘要翻译: 描述和要求保护编码的遗传结构的组合物和用于产生多价抗原结合蛋白的方法。 所述方法包括纯化含有单一和多价形式的单一多肽链分子的组合物,以及从纯化单体制备多价蛋白质。 多价蛋白质的产生可以通过单体蛋白质的浓度依赖性缔合,或者通过重新排列涉及解离的区域,然后重新结合不同的区域来进行。 在本发明中制备了包含同型和异二价蛋白质的二价蛋白质。 公开了编码二价单链抗原结合蛋白的遗传序列。 用途包括适用于单克隆和多克隆抗体及其片段的所有应用,包括用作双特异性抗原结合分子。

    Anti-erbB-2 antibodies, combinations thereof, and therapeutic and
diagnostic uses thereof
    7.
    发明授权
    Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof 失效
    抗erbB-2抗体,其组合,及其治疗和诊断用途

    公开(公告)号:US5587458A

    公开(公告)日:1996-12-24

    申请号:US61092

    申请日:1993-05-14

    CPC分类号: C07K16/32 A61K38/00

    摘要: The present invention relates to novel antibodies, in particular monoclonal and single chain antibodies derived therefrom which specifically bind to erbB-2, as well as diagnostic and therapeutic uses thereof. The present invention also relates to a combination of at least two erbB-2 specific antibodies which are capable of preventing and treating human malignancies wherein the malignant cells overexpress gp185.sup.erbB-2. The monoclonal antibodies of the combination preferably recognize different epitopes of the gp185 expression product of erbB-2, therefore, the antibodies do not cross react with each other. Preferably, the combination will provide for synergistic decrease in the expression of the erbB-2 gene product.

    摘要翻译: 本发明涉及特异性结合erbB-2的新型抗体,特别是衍生自其的单克隆抗体和单链抗体,以及其诊断和治疗用途。 本发明还涉及能够预防和治疗恶性细胞过表达gp185erbB-2的人类恶性肿瘤的至少两种erbB-2特异性抗体的组合。 组合的单克隆抗体优选识别erbB-2的gp185表达产物的不同表位,因此,抗体彼此不交叉反应。 优选地,组合将提供erbB-2基因产物的表达的协同降低。